IDEXX Laboratories (IDXX) : Analyst Rating Update

IDEXX Laboratories (IDXX) : The consensus on IDEXX Laboratories (IDXX) based on 7 analyst recommendation on the company stock is 2.43, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 3 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 3 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 1 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.

IDEXX Laboratories (IDXX) stock is expected to deviate a maximum of $17.74 from the average target price of $77.8 for the short term period. 5 Street Experts have initiated coverage on the stock with the most promising target being $92 and the most muted being $47.

IDEXX Laboratories (NASDAQ:IDXX): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $93.50 and $92.72 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $93.70. The buying momentum continued till the end and the stock did not give up its gains. It closed at $93.57, notching a gain of 0.20% for the day. The total traded volume was 502,925 . The stock had closed at $93.38 on the previous day.

Also, Credit Suisse maintains their rating on the shares of IDEXX Laboratories (NASDAQ:IDXX). The current rating of the shares is Outperform. Equity Analysts at the Firm raises the price target to $85 per share from $80 per share. The rating by the firm was issued on April 13, 2016. The company shares have rallied 50.71% from its 1 Year high price. On Jul 5, 2016, the shares registered one year high at $93.69 and the one year low was seen on Jul 8, 2015. The 50-Day Moving Average price is $89.31 and the 200 Day Moving Average price is recorded at $78.96.

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy, and Other. Its Products and services include point-of-care veterinary diagnostic products; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems; biological materials testing, laboratory animal diagnostic instruments and services; diagnostic, health-monitoring and food safety testing products for livestock, poultry and dairy; products that test water for microbiological contaminants, and point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.